Literature DB >> 9028391

Multiple myeloma: prognosis and standard treatment.

M M Oken1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9028391     DOI： 10.3109/07357909709018918

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  2 in total

Review 1.  Current drug therapy for multiple myeloma.

Authors:  Y W Huang; A Hamilton; O J Arnuk; P Chaftari; R Chemaly
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

2.  Elevated level of plasma basic fibroblast growth factor in multiple myeloma correlates with increased disease activity.

Authors:  Norihide Sato; Yutaka Hattori; Du Wenlin; Taketo Yamada; Tamihiro Kamata; Tsunayuki Kakimoto; Shinichiro Okamoto; Chiharu Kawamura; Masahiro Kizaki; Naoki Shimada; Yukiko Ote; Jun-ichi Hata; Yasuo Ikeda
Journal:  Jpn J Cancer Res       Date:  2002-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.